Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study.
HoJin ShinSebastian G SchneeweissRobert J GlynnElisabetta PatornoPublished in: Annals of internal medicine (2022)
Brigham and Women's Hospital and Harvard Medical School.